Biglycan anticorps (Middle Region)
Aperçu rapide pour Biglycan anticorps (Middle Region) (ABIN633950)
Antigène
Voir toutes Biglycan (BGN) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Middle Region
-
Specificité
- BGN antibody was raised against the middle region of BGN
-
Purification
- Affinity purified
-
Immunogène
- BGN antibody was raised using the middle region of BGN corresponding to a region with amino acids ISEAKLTGIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQ
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
BGN Blocking Peptide, (ABIN939533), is also available for use as a blocking control in assays to test for specificity of this BGN antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of BGN antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- Biglycan (BGN)
-
Autre désignation
- BGN
-
Sujet
- The protein encoded by this gene is a small cellular or pericellular matrix proteoglycan that is closely related in structure to two other small proteoglycans, decorin and fibromodulin.
-
Poids moléculaire
- 37 kDa (MW of target protein)
-
Pathways
- Glycosaminoglycan Metabolic Process
Antigène
-